38 results on '"Rudolph P. Valentini"'
Search Results
2. Papilloedema and renal failure in an adolescent presenting to the emergency department
- Author
-
Carolina Vega, Rudolph P. Valentini, Nirupama Kannikeswaran, and Usha Sethuraman
- Subjects
business.industry ,Pediatrics, Perinatology and Child Health ,Medicine ,Emergency department ,Medical emergency ,business ,medicine.disease - Published
- 2021
3. Clinical profile of children incidentally found to have advanced kidney failure
- Author
-
Rossana Baracco, Melissa J. Gregory, Rudolph P. Valentini, Gaurav Kapur, Wael M. Abukwaik, and Amrish Jain
- Subjects
Nephrology ,medicine.medical_specialty ,Hyperparathyroidism ,Anemia ,business.industry ,medicine.medical_treatment ,medicine.disease ,Hyperphosphatemia ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Epidemiology ,Cohort ,medicine ,business ,Dialysis ,Kidney disease - Abstract
No data exist on the epidemiology of children incidentally diagnosed with advanced kidney failure (KF) during evaluation for non-specific symptoms. This is likely related to unrecognized symptoms and signs of CKD. The objective of our study was to evaluate incidentally diagnosed patients with advanced KF requiring long-term kidney replacement therapy (KRT). An IRB-approved retrospective chart review of children who started KRT with dialysis (hemo- or peritoneal) was conducted. Included were children with no prior knowledge or diagnosis of underlying kidney disease with chronic kidney disease (CKD) disease stage 4 (GFR 15–29 mL/min/1.73 m2) or 5 (GFR
- Published
- 2021
4. Acute Kidney Injury in Pediatric Acute SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children (MIS-C): Is There a Difference?
- Author
-
Rudolph P. Valentini, Manpreet K. Grewal, Dunya Mohammad, Melissa J. Gregory, Amrish Jain, Ronald Thomas, Katherine Cashen, and Jocelyn Y. Ang
- Subjects
Inotrope ,medicine.medical_specialty ,business.industry ,Acute kidney injury ,Renal function ,COVID-19 ,Odds ratio ,medicine.disease ,Pediatrics ,RJ1-570 ,Pathophysiology ,Pathogenesis ,Capillary leak ,acute kidney injury ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Medicine ,risk factors ,Stage (cooking) ,business ,multisystem inflammatory syndrome in children ,pathophysiology ,Original Research - Abstract
Objective: To evaluate the prevalence and factors associated with the risk of acute kidney injury (AKI) in pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and multisystem inflammatory syndrome in children (MIS-C).Study Design: We performed a retrospective chart review of 113 patients with SARS-CoV-2 infection with or without MIS-C admitted at Children's Hospital of Michigan (CHM) from March to August 2020. Patient demographic details, laboratory data, imaging studies, echocardiography reports, and treatment data were collected.Results: Of the 92 patients included in the final analysis, 22 (24%) developed AKI with 8/22 (36%) developing stage 3 AKI. The prevalence of AKI was much higher in patients with MIS-C 15/28 (54%) vs. those with acute SARS-CoV-2 infection 7/64 (11%), (p < 0.001). Overall, when compared to patients without AKI, patients with AKI were older in age (11 vs. 6.5 years, p = 0.007), African American (86 vs. 58%, p = 0.028), had MIS-C diagnosis (68 vs. 19%, p < 0.001), required ICU admission (91 vs. 20%, p < 0.001), had cardiac dysfunction (63 vs. 16%, p < 0.001), required inotropic support (59 vs. 6%, p < 0.001) and had a greater elevation in inflammatory markers. In a multivariate analysis, requirement of inotropes [Odds Ratio (OR)−22.8, p < 0.001], African American race (OR-8.8, p = 0.023) and MIS-C diagnosis (OR-5.3, p = 0.013) were the most significant predictors for AKI. All patients had recovery of kidney function, and none required kidney replacement therapy.Conclusion: Children with acute SARS-CoV-2 infection and MIS-C are at risk for AKI, with the risk being significantly greater with MIS-C. The pathogenesis of AKI in acute SARS-CoV-2 infection appears to be a combination of both renal hypo-perfusion and direct renal parenchymal damage whereas in MIS-C, the renal injury appears to be predominantly pre-renal from cardiac dysfunction and capillary leak from a hyperinflammatory state. These factors should be considered by clinicians caring for these children with a special focus on renal protective strategies to aid in recovery and prevent additional injury to this high-risk subgroup.
- Published
- 2021
5. Chronic Kidney Disease: Treatment of Comorbidities II (Hypertension, Anemia, and Electrolyte Management)
- Author
-
Rudolph P. Valentini and Deepa H. Chand
- Subjects
medicine.medical_specialty ,education.field_of_study ,Hyperkalemia ,business.industry ,Anemia ,Mortality rate ,Population ,Metabolic acidosis ,Disease ,medicine.disease ,Blood pressure ,Pediatrics, Perinatology and Child Health ,Medicine ,medicine.symptom ,business ,Intensive care medicine ,education ,Kidney disease - Abstract
While the causes of chronic kidney disease (CKD) are different in children than their adult counterparts, many comorbidities are commonly encountered by both populations. Particularly concerning is that these entities contribute to the decrease in lifespan in children with CKD. Amongst these conditions are hypertension, anemia, and electrolyte abnormalities. While these can cause metabolic derangements individually, they each contribute to the development and progression of cardiovascular disease, which in turn, exponentially increases mortality (Vidi Curr Opin Pediatr 30 (2): 247-251, 2018). It has been estimated that the mortality rate of children with CKD is 30 times higher than their healthy peers (Ferris et al. Blood Purif 41 (1-3): 205-10, 2016). As these conditions are each treatable, optimization of medical management can lessen the risk of death in this high-risk population. Hypertension remains underdiagnosed in children with CKD despite a high prevalence. The American Academy of Pediatrics released the Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents in 2007, in which experts outline the need for aggressive diagnosis and treatment of hypertension. While the mainstay of anemia management remains correction of iron deficiency and erythropoiesis stimulating agents, long-acting erythropoietic agents offer an alternative option to traditional management. Electrolyte abnormalities including metabolic acidosis and hyperkalemia must be addressed in order to optimize clinical outcomes. The care of children with CKD remains complex with the need for a wholistic approach. Although the injury initiates within the kidneys, the associated comorbidities have systemic consequences. Some of these include hypertension, anemia, and electrolyte abnormalities. The early identification of these conditions as well as aggressive treatment can improve the health of these children.
- Published
- 2019
6. Reducing central venous catheters in chronic hemodialysis—a commitment to arteriovenous fistula creation in children
- Author
-
Rossana Baracco, Tej K. Mattoo, Rudolph P. Valentini, Gaurav Kapur, and Amrish Jain
- Subjects
Male ,Nephrology ,Catheterization, Central Venous ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Vascular access ,Arteriovenous fistula ,Surgical methods ,Arteriovenous Shunt, Surgical ,Renal Dialysis ,Internal medicine ,medicine ,Central Venous Catheters ,Humans ,Chronic hemodialysis ,cardiovascular diseases ,Child ,Retrospective Studies ,business.industry ,Retrospective cohort study ,equipment and supplies ,medicine.disease ,Surgery ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Kidney Failure, Chronic ,Female ,business ,Central venous catheter - Abstract
An internal permanent vascular access [arteriovenous fistula (AVF) or arteriovenous graft (AVG)] is preferred over central venous catheters (CVC) for chronic hemodialysis. However, CVC remain the most commonly used access in children. The objective of this study was to evaluate our experience with AVF.We conducted a retrospective chart review of children aged 1-18 years on chronic hemodialysis from 2001 to 2012. Patients were divided into three time periods: 2001-2005, 2006-2009 and 2010-2012. A systematic approach to AVF placement was introduced in our department in 2006 which resulted in a greater number of AVF being placed and used, but the access failure rate was still higher than desired. In 2010, a more experienced vascular surgeon was contacted to perform AVF surgery in our most difficult AVF candidates.Sixty-five AVF were created in 55 patients (67.3 % male). The median age of the patients was 14 (3-18) years. Forty-one (63.1 %) AVF were used successfully, and this number increased from 52.6 to 57.6 to 92.3 % over the three time periods, respectively. Over time, AVF use rates increased and CVC use decreased. By 2012 only 7.7 % of our patients were using a CVC. The primary patency rate was 42.9 % at 1 year; secondary patency rates were 100 and 93.8 % at 1 and 2 years, respectively. Infection and hospitalization rates were higher for CVC than for AVF [0.8 vs. 0.1 infections per access-year (p 0.001) and 0.9 vs. 0.2 hospitalizations per access-year (p 0.001)].With a dedicated approach and vascular access team it is possible to decrease CVC and increase AVF use in children on hemodialysis. In our study, increased AVF use resulted in decreased access-related infection and hospitalization rates.
- Published
- 2014
7. Race-specific relationship of birth weight and renal function among healthy young children
- Author
-
Andrea E. Cassidy-Bushrow, Charles Barone, Ganesa Wegienka, Christine Cole Johnson, Suzanne Havstad, Rudolph P. Valentini, and Jerry Yee
- Subjects
Male ,Nephrology ,medicine.medical_specialty ,Birth weight ,Renal function ,Physiology ,Kidney ,urologic and male genital diseases ,Article ,Race (biology) ,Internal medicine ,medicine ,Birth Weight ,Humans ,business.industry ,Infant ,medicine.disease ,Black or African American ,Low birth weight ,Endocrinology ,Increased risk ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Linear Models ,Female ,medicine.symptom ,business ,Glomerular Filtration Rate ,Kidney disease - Abstract
Low birth weight is associated with diminished renal function. However, despite African Americans being at increased risk of low birth weight and chronic kidney disease, little is known about the association between birth weight and renal function in diverse groups. We examined racial differences in the relationship of birth weight and renal function among healthy young children.Birth weight and serum creatinine data were available on 152 children (61.8% African American; 47.4% female) from a birth cohort. Estimated glomerular filtration rate (eGFR) was calculated using the bedside Schwartz equation and gender- and gestational-age-adjusted birth weight Z-scores using the US population as a reference. Race-specific linear regression models were fit to estimate the association between birth weight Z-score and eGFR.Mean age was 1.5 ± 1.3 years at first eGFR measurement. African Americans had lower eGFR than non-African Americans (median eGFR = 82 vs. 95 ml/min per 1.73 m(2); p = 0.06). Birth weight was significantly and positively associated with eGFR among African American (p = 0.012) but not non-African American children (p = 0.33).We provide, for the first time, evidence suggesting that birth weight is associated with renal function in African American children. Future work is needed to determine if prenatal programming helps explain racial disparities in adult health.
- Published
- 2012
8. Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?
- Author
-
Sermin A. Saadeh, Gaurav Kapur, Rudolph P. Valentini, Tej K. Mattoo, Rossana Baracco, and Amrish Jain
- Subjects
Nephrology ,Body surface area ,medicine.medical_specialty ,business.industry ,Urology ,medicine.disease ,Response to treatment ,Actual weight ,Endocrinology ,Prednisone ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Cohort ,medicine ,Dosing ,business ,Nephrotic syndrome ,medicine.drug - Abstract
Although prednisone is the treatment of choice for nephrotic syndrome (NS) in childhood, the dosing regimen varies between 60 mg/m(2)/day, as recommended in early studies, to the often prescribed 2 mg/kg/day dose, which is used in common practice. Mathematical models have demonstrated that weight-based dosing can be less than body surface area (BSA)-based dosing in smaller children. To test our hypothesis that weight-based dosing would result in altered treatment outcomes in children with NS, we analyzed a cohort of 56 children (mean age 5.4 ± 3.8 years) treated with a weight-based dosing regimen. Theoretical underdosing of corticosteroids was tested by calculating a relative underdosing percentage (RUP), which was defined as the dose difference between the theoretical BSA-based dose and the actual weight-based doses divided by the BSA-based dose × 100. We found that the mean "actual" prednisone dose in our patients was 43.6 ± 19.3 mg/day; in contrast, the mean theoretical BSA-based dose was calculated to be 48.8 ± 16.7 mg/day. Among the 56 patients, 43 (76.7%) were initial responders, of whom 58% followed a frequently relapsing (FR) course. RUP was significantly higher in FR (16.6 ± 7.9%) than in infrequent relapsers (8.7 ± 9.8%) (P = 0.03). RUP was not significantly different among initial responders and nonresponders. Based on these results, we conclude that prednisone underdosing, when dosing is prescribed according to weight, does not affect the initial response to treatment, but it does increase the likelihood of a FR course in responders.
- Published
- 2011
9. Iron deficiency in children with early chronic kidney disease
- Author
-
Amrish Jain, Gaurav Kapur, Tej K. Mattoo, Rossana Baracco, Sermin A. Saadeh, and Rudolph P. Valentini
- Subjects
Male ,Nephrology ,Pathology ,medicine.medical_specialty ,Adolescent ,Anemia ,Iron ,Population ,Renal function ,urologic and male genital diseases ,Gastroenterology ,Internal medicine ,medicine ,Humans ,Child ,education ,Retrospective Studies ,education.field_of_study ,biology ,business.industry ,Transferrin saturation ,Iron Deficiencies ,Iron deficiency ,medicine.disease ,female genital diseases and pregnancy complications ,Ferritin ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,biology.protein ,Kidney Failure, Chronic ,Female ,business ,Kidney disease - Abstract
Iron deficiency (ID) contributes to the development of anemia in patients with chronic kidney disease (CKD). The frequency of ID in children with early CKD has not previously been reported. This was a retrospective chart review of children with CKD stages 2 and 3 followed at the CKD clinic of Children's Hospital of Michigan. ID was defined as low ferritin and transferrin saturation20%. Patients on iron supplements were considered as iron-deficient cases. There were 50 patients included in the study (72% male) with a mean age of 10.31 (±5.21). The mean glomerular filtration rate (GFR) was 55.4 ml/min/1.73 m(2) (±14.61). ID was present in 42% of patients, out of whom almost half (42.9%) presented with anemia. Females had a higher frequency of ID (64.3%). The frequency of ID with anemia increased from 4.3% to 29.6%, (p = 0.03) in stage 2 to stage 3 CKD, respectively. The frequency of ID without anemia also increased with progression of CKD from stage 2 to stage 3, however, the difference was not statistically significant. ID is frequent in patients with early CKD. Monitoring of iron tests and treatment of ID is important in this population of patients.
- Published
- 2011
10. Vitamin D Deficiency and Arterial Wall Stiffness in Children With Chronic Kidney Disease
- Author
-
Wei Du, Rudolph P. Valentini, Michael D. Pettersen, and Amit R. Patange
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Renal function ,Left ventricular hypertrophy ,vitamin D deficiency ,Vascular Stiffness ,Internal medicine ,medicine ,Vitamin D and neurology ,Humans ,Renal Insufficiency, Chronic ,Vitamin D ,Child ,business.industry ,Phosphorus ,Vitamin D Deficiency ,medicine.disease ,Endocrinology ,Pediatrics, Perinatology and Child Health ,Arterial stiffness ,Cardiology ,Regression Analysis ,Calcium ,Female ,Aortic stiffness ,Hemodialysis ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Kidney disease - Abstract
Arterial wall stiffness is a recognized complication in children with chronic kidney disease (CKD). Vascular abnormalities in these patients are shown to predate cardiac abnormalities such as left ventricular hypertrophy and diastolic dysfunction. The etiology of vascular abnormalities in these patients currently is not clear. This study explored the relationship between various parameters of calcium-phosphorus metabolism including 25-hydroxy vitamin D and arterial wall stiffness in pediatric patients with CKD. This study investigated a cohort of 43 children with CKD who had no history of underlying congenital or structural cardiac disease. The Augmentation Index (AI), a measure of peripheral arterial reflective properties using radial artery tonometry, was used as an indirect measure of central aortic stiffness. Serum biochemical markers of calcium-phosphorus metabolism were simultaneously measured. Univariate testing showed that AI correlated with worsening kidney function. Serum 25-hydroxy vitamin D levels were low and correlated negatively with AI (r = -0.39; p < 0.05). Multiple regression analysis showed that 25-hydroxy vitamin D was the only significant independent predictor of increased central arterial stiffness in the subgroup of children receiving hemodialysis. No association was observed between AI and any other measured biochemical parameter of calcium-phosphorus metabolism. This is the first study to investigate pediatric patients with CKD that suggests an association between nutritional vitamin D deficiency and increased arterial stiffness in children with CKD. The pathophysiologic mechanisms of vitamin D that regulate increased arterial stiffness need to be integrated further in pediatric CKD patients.
- Published
- 2011
11. Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study
- Author
-
Amy C. Wilson, Jeffrey D. Leiser, Rudolph P. Valentini, John D. Mahan, Henrietta Hall, Corina Nailescu, Hong Zhou, Xiyan Xu, Deepa H. Chand, and Diane Hebert
- Subjects
Graft Rejection ,Male ,Nephrology ,Canada ,medicine.medical_specialty ,Time Factors ,Adolescent ,Influenza vaccine ,medicine.medical_treatment ,Antibodies, Viral ,medicine.disease_cause ,Influenza A Virus, H1N1 Subtype ,Internal medicine ,Influenza, Human ,Influenza A virus ,medicine ,Humans ,Seroconversion ,Child ,Immunization Schedule ,Kidney transplantation ,Chi-Square Distribution ,business.industry ,Influenza A Virus, H3N2 Subtype ,Immunosuppression ,Hemagglutination Inhibition Tests ,medicine.disease ,Kidney Transplantation ,United States ,Transplantation ,Vaccination ,Treatment Outcome ,Influenza Vaccines ,Acute Disease ,Pediatrics, Perinatology and Child Health ,Immunology ,Female ,Steroids ,business ,Immunosuppressive Agents - Abstract
The main aim of this study was to compare the response to trivalent inactivated influenza vaccine in children who received a kidney transplant and were on steroid-free versus steroid-based immunosuppression. Groups: 1. Kidney transplant recipients on steroid-free immunosuppression (n = 27); 2. Kidney transplant recipients on steroid-based immunosuppression (n = 39); 3. Healthy controls (n = 21). Hemagglutination inhibition titers against 2007–2008 A/H1N1 and A/H3N2 and B strains were measured before and 8 weeks postvaccination. Postvaccination geometric mean titers to A/H1N1 were significantly lower among both transplant groups than controls (p = 0.025 and 0.015, respectively). Postvaccination titers to H3N2 and B strains were not statistically different between groups. Proportions of participants developing seroprotection were not different among groups. Both kidney transplant groups seroconverted less than controls for A/H1N1 (p = 0.0002) and were no different from controls for B. For A/H3N2, the steroid-free group had the weakest seroconversion (p = 0.008), possibly due to mycophenolate-enhanced exposure and a younger age. Overall, children after kidney transplantation demonstrated a good serologic response to the inactivated influenza vaccine although somewhat lower than controls. Steroid-free immunosuppression did not seem to present an advantage in antibody response. Data on inactivated influenza vaccine safety and efficacy was collected and demonstrated absence of acute rejection or laboratory-proven influenza for 6 months postvaccination.
- Published
- 2010
12. Membranous glomerulonephritis: treatment response and outcome in children
- Author
-
Abubakr Imam, Tej K. Mattoo, Gaurav Kapur, and Rudolph P. Valentini
- Subjects
Male ,Nephrology ,medicine.medical_specialty ,Nephrotic Syndrome ,Adolescent ,Biopsy ,Renal function ,Idiopathic membranous glomerulonephritis ,Glomerulonephritis, Membranous ,Gastroenterology ,Cohort Studies ,Prednisone ,Internal medicine ,medicine ,Humans ,Child ,Cyclophosphamide ,Retrospective Studies ,Proteinuria ,business.industry ,Remission Induction ,Glomerulonephritis ,medicine.disease ,Treatment Outcome ,Endocrinology ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Female ,medicine.symptom ,business ,Nephrotic syndrome ,Immunosuppressive Agents ,medicine.drug ,Kidney disease - Abstract
The aim of this study was to characterize clinical features, treatment response, and outcome of idiopathic membranous glomerulonephritis (MGN) in a single-center cohort of children. A retrospective review of biopsy-proven idiopathic MGN in 12 children (mean age 11.9 years) was undertaken. Presentation was nephrotic syndrome (NS) (75%), hematuria/proteinuria (17%), and asymptomatic proteinuria (8%). Ten patients (83%) with NS and nephrotic range proteinuria (NRP) were treated with prednisone, and two patients with non-NRP were not treated with immunosuppressive medications. Steroid response in the treated patients was complete (10%), partial (40%), and absent (50%), respectively. Oral cyclophosphamide was used in seven patients of whom five were steroid resistant, one was steroid dependent, and one was partially responsive. At the mean follow up of 27 months, outcome parameters included an estimated glomerular filtration rate of 128 cc/min per 1.73 m(2), albumin of 4.2 gm/dL, and a urine protein/creatinine ratio of 0.87 [median 0.16 (range 0.02-6.52)]. Remission was complete in 75% of the patients and partial in 17%. One patient (8%) with chronic kidney disease (stage 2) was unresponsive to therapy. Complete remission was significantly associated with the absence of chronic histological changes (p = 0.03). In conclusion, children with NS and/or NRP associated with MGN appear to have a good prognosis when treated with a combination of corticosteroids and cyclophosphamide.
- Published
- 2009
13. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease
- Author
-
Tej K. Mattoo, Shina Menon, Rudolph P. Valentini, Guillermo Hidalgo, and Lena Peschansky
- Subjects
Male ,Nephrology ,medicine.medical_specialty ,Adolescent ,Gastroenterology ,vitamin D deficiency ,Calcitriol ,Internal medicine ,Prevalence ,medicine ,Vitamin D and neurology ,Humans ,Child ,Retrospective Studies ,Hyperparathyroidism ,business.industry ,Retrospective cohort study ,Vitamin D Deficiency ,medicine.disease ,Ergocalciferol ,Endocrinology ,Parathyroid Hormone ,Child, Preschool ,Chronic Disease ,Pediatrics, Perinatology and Child Health ,Female ,Kidney Diseases ,business ,Homeostasis ,medicine.drug ,Kidney disease - Abstract
Chronic kidney disease (CKD) is associated with altered calcium-phosphate homeostasis and hyperparathyroidism due to decreased activity of 1alpha-hydroxylase and impaired activation of 25-hydroxyvitamin D3 [25(OH)D3]. In some patients these problems start earlier because of vitamin D deficiency. A retrospective review of patients followed in the chronic renal insufficiency clinic at Children's Hospital of Michigan assessed the prevalence of vitamin D deficiency in CKD stages 2-4 and evaluated the effect of treatment with ergocalciferol on serum parathormone (PTH). Blood levels of 1,25 dihydroxyvitamin D3, 25(OH)D3, and parathormone (PTH) were examined in 57 children (40 boys; mean age 10.6 years). Of 57 subjects, 44 (77.2%) had 25(OH)D3 levelsor =30 ng/ml, with overall mean of 26.4 +/- 14.3 ng/ml. PTH for patients with 25(OH)D3 levels30 ng/ml was 67.84 +/- 29.09 ng/ml and in the remaining patients was elevated, at 120.36 +/- 86.42 ng/ml (p = 0.05). Following ergocalciferol treatment (22), PTH decreased from 122.13 +/- 82.94 ng/ml to 80.14 +/- 59.24 ng/ml (p0.001) over a period of 3 months. We conclude that vitamin D deficiency is common in children with CKD stages 2-4 and is associated with hyperparathyroidism in the presence of normal 1,25 dihydroxyvitamin D3. Its occurrence before significant renal impairment is noteworthy. Early diagnosis and appropriate treatment is emphasized.
- Published
- 2008
14. Ceftriaxone induced hemolysis complicated by acute renal failure
- Author
-
Tej K. Mattoo, Gaurav Kapur, Indira Warrier, Rudolph P. Valentini, and Abubakr A. Imam
- Subjects
Male ,Hemolytic anemia ,Anemia, Hemolytic ,Anemia ,medicine.medical_treatment ,Tachypnea ,Pallor ,Case fatality rate ,medicine ,Humans ,Child ,Dialysis ,business.industry ,Ceftriaxone ,Hematology ,Acute Kidney Injury ,Kidney Tubular Necrosis, Acute ,medicine.disease ,Anti-Bacterial Agents ,Oncology ,Shock (circulatory) ,Anesthesia ,Pediatrics, Perinatology and Child Health ,medicine.symptom ,business ,medicine.drug - Abstract
Over the last decade, second and third generation cephalosporins have been the most common drugs causing hemolytic anemia (HA). Of these cases, 20% have been attributed to ceftriaxone. The clinical presentation of ceftriaxone-induced HA is usually abrupt with sudden onset of pallor, tachypnea, cardio-respiratory arrest and shock. Acute renal failure (ARF) has been reported in 41% of such cases with a high fatality rate. We report a pediatric patient with ARF complicating ceftriaxone-induced HA who survived. Ceftriaxone is a commonly used drug, and early recognition of HA and institution of supportive care, including dialysis is likely to improve the outcome.
- Published
- 2008
15. Central venous lines for chronic hemodialysis: survey of the Midwest Pediatric Nephrology Consortium
- Author
-
Rudolph P. Valentini, Deepa H. Chand, and Denis F. Geary
- Subjects
Nephrology ,Catheterization, Central Venous ,medicine.medical_specialty ,medicine.medical_treatment ,Tissue plasminogen activator ,Catheters, Indwelling ,Renal Dialysis ,Surveys and Questionnaires ,Internal medicine ,medicine ,Humans ,Pediatric nephrology ,Prospective cohort study ,Dialysis ,business.industry ,Heparin ,Surgery ,Catheter ,Cross-Sectional Studies ,Health Care Surveys ,Pediatrics, Perinatology and Child Health ,Kidney Failure, Chronic ,Equipment Failure ,Hemodialysis ,business ,medicine.drug - Abstract
Central venous lines (CVL) continue to be the most commonly used vascular access device for children on hemodialysis (HD). Despite their frequent use, little is known regarding the frequency of CVL-related intradialytic complications that could interfere with delivery of effective dialysis. To better assess this, we conducted a cross-sectional study of ten HD centers within the Midwest Pediatric Nephrology Consortium. Vascular access was provided by CVL in 61 of the 83 patients (73%) included. CVL dysfunction (defined as reduced blood flows, need for reversed lines, or frequent intradialytic alarms) occurred in 46% in the prior month. Treatment for suspected clots occurred in 16 patients. Intraluminal tissue plasminogen activator (tPA) was the preferred treatment for a suspected clot. The survey also inquired about the preferred treatment for documented clots, and intraluminal tPA was most preferred, followed by CVL stripping, CVL removal, CVL brushing, and systemic tPA. As for preventative strategies, most HD centers locked the CVL with intraluminal heparin in concentrations ranging from 1,000 to 5,000 U/ml. In conclusion, catheter usage rates and complications were highly prevalent in pediatric HD units in this study. As treatment strategies varied greatly, future prospective studies are needed to determine the effectiveness of each individual therapy.
- Published
- 2007
16. Serum Osmolal Gap in Patients With Idiopathic Nephrotic Syndrome and Severe Edema
- Author
-
Amrish Jain, Rudolph P. Valentini, Tej K. Mattoo, Gaurav Kapur, and Abubakr A. Imam
- Subjects
Male ,Serum ,medicine.medical_specialty ,Nephrotic Syndrome ,Idiopathic Nephrotic Syndrome ,Internal medicine ,Hyperlipidemia ,Edema ,Humans ,Medicine ,In patient ,Hypoalbuminemia ,Child ,Osmole ,business.industry ,Osmolar Concentration ,Severe edema ,medicine.disease ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Cardiology ,Female ,business ,Hyponatremia ,Nephrotic syndrome - Abstract
Pseudohyponatremia in idiopathic nephrotic syndrome with severe edema is attributed to hyperlipidemia that results in displacement of a portion of water phase of plasma. Current methods of measurement of serum electrolytes are unaffected by hyperlipidemia. In this report we demonstrate that patients with idiopathic nephrotic syndrome with severe edema and true hyponatremia may have an increased rather than normal osmolal gap. We believe that this could be secondary to non-Na+ and non-K+ osmoles in response to plasma-volume contraction secondary to hypoalbuminemia. This observation has implications for management of severe edema in such patients, because fluid restriction could increase their risk for pre–renal failure.
- Published
- 2007
17. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients
- Author
-
Cheryl Lang, Sandra L. Nehlsen-Cannarella, Abubakr A. Imam, Rudolph P. Valentini, Tej K. Mattoo, Scott A. Gruber, and Miguel S. West
- Subjects
Reoperation ,Urinary system ,Human leukocyte antigen ,Antibodies ,medicine ,Humans ,Transplantation, Homologous ,Child ,Kidney transplantation ,Immunosuppression Therapy ,Transplantation ,Kidney ,biology ,Donor selection ,business.industry ,Histocompatibility Testing ,Panel reactive antibody ,Immunoglobulins, Intravenous ,medicine.disease ,Kidney Transplantation ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Immunology ,biology.protein ,Immunization ,Antibody ,business ,Immunosuppressive Agents ,Software - Abstract
The use of intravenous immunoglobulin (IVIG) in sensiti- zed transplant candidates has resulted in reduced HLA antibody levels and shorter transplant wait times. In addition, the HLA- Matchmaker program has been used to identify acceptable mis- matches to permit transplantation in highly sensitized patients. We used IVIG desensitization in conjunction with high resolution HLA allele typing and HLAMatchmaker grading of donor offers to facilitate successful transplantation in two highly sensitized children who were awaiting second renal transplants. Both patients lost their initial transplant in
- Published
- 2007
18. Calciphylaxis in pediatric end-stage renal disease
- Author
-
Rudolph P. Valentini, Tej K. Mattoo, Abubakr A. Imam, David A. Bloom, and Gaurav Kapur
- Subjects
Male ,Nephrology ,medicine.medical_specialty ,Adolescent ,Biopsy ,medicine.medical_treatment ,Pain ,Sevelamer ,Peritoneal dialysis ,End stage renal disease ,Fatal Outcome ,Internal medicine ,medicine ,Humans ,Muscle, Skeletal ,Skin ,Calciphylaxis ,Muscle biopsy ,medicine.diagnostic_test ,business.industry ,Phosphorus ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,Parathyroid Hormone ,Pediatrics, Perinatology and Child Health ,Kidney Failure, Chronic ,Calcium ,business ,Peritoneal Dialysis ,medicine.drug ,Calcification - Abstract
Calciphylaxis is a rare, but life-threatening complication of end-stage renal disease (ESRD) that has been reported mostly in adult patients. The exact etiology is unknown, but the disease is commonly associated with a high calcium-phosphorus product and elevated levels of parathyroid hormone (PTH). We herein review the published reports on calciphylaxis in ESRD patients less than 18 years old and report the case of a patient with severe calciphylaxis who presented with lower extremity pain, muscle tenderness and difficulty in walking. The serum PTH was low, and the calcium-phosphorus product was normal. The diagnosis of calciphylaxis was confirmed by a muscle biopsy. Treatment with low calcium peritoneal dialysate and substitution of calcium-based phosphorus binders with sevelamer (Renagel) was unsuccessful. The patient's clinical condition progressed to extensive soft tissue calcification and ulcerating skin lesions. Nine months after the onset of symptoms, the patient died of cardiopulmonary arrest.
- Published
- 2005
19. An adolescent on peritoneal dialysis with acute encephalopathy: Answers
- Author
-
Rudolph P. Valentini, Tej K. Mattoo, Gaurav Kapur, Rossana Baracco, Lawrence Ku, Amrish Jain, and Murty Adabala
- Subjects
Nephrology ,Pediatrics ,medicine.medical_specialty ,Wernicke Encephalopathy ,business.industry ,medicine.medical_treatment ,Acute encephalopathy ,medicine.disease ,Peritoneal dialysis ,End stage renal disease ,chemistry.chemical_compound ,Peripheral neuropathy ,chemistry ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Intensive care medicine ,business ,Thiamine deficiency - Published
- 2013
20. Renal papillary necrosis induced by naproxen
- Author
-
Neena Gupta, Abubakr Imam, Rudolph P. Valentini, Jay Bernstein, Tej K. Mattoo, and Larisa Kovacevic
- Subjects
Nephrology ,medicine.medical_specialty ,Adolescent ,Urinalysis ,Interstitial nephritis ,Renal papillary necrosis ,Gastroenterology ,Nephrotoxicity ,Necrosis ,chemistry.chemical_compound ,Naproxen ,Internal medicine ,medicine ,Humans ,Acute tubular necrosis ,Kidney Medulla ,Kidney ,Creatinine ,medicine.diagnostic_test ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Acute Kidney Injury ,medicine.disease ,Surgery ,medicine.anatomical_structure ,chemistry ,Pediatrics, Perinatology and Child Health ,Female ,business - Abstract
A 17-year-old healthy girl was admitted to our hospital with diffuse abdominal pain and decreased oral intake of about 11 days duration. About a week prior to admission, she had taken naproxen, 250 mg four times a day for 4 days. Physical examination was normal except for diffuse abdominal tenderness on deep palpation. Investigations revealed high serum BUN (42 mg/dl) and creatinine (4.0 mg/dl). Serum electrolytes and complement (C3, C4) levels and urinalysis were normal. Antinuclear-antibody and anti-dsDNA were negative. Kidney biopsy revealed renal papillary necrosis, acute tubular necrosis, and focal interstitial nephritis. A diagnosis of nonoliguric acute renal failure due to naproxen nephrotoxicity was made. She received intravenous hydration, and oral steroids, which was gradually discontinued in 3 months. A follow-up at 4 months revealed normal renal function with a serum creatinine of 1.1 mg/dl, BUN 7 mg/dl, and normal urinalysis. The report highlights a need for caution while using naproxen or any other nonsteroidal anti-inflammatory drugs, even for a short duration.
- Published
- 2003
21. Outcome of antineutrophil cytoplasmic autoantibodies-positive glomerulonephritis and vasculitis in children: A single-center experience
- Author
-
Rudolph P. Valentini, Aileen B. Sedman, Melissa Gregory, David B. Kershaw, William E. Smoyer, and Timothy E. Bunchman
- Subjects
Male ,Vasculitis ,Pathology ,medicine.medical_specialty ,Adolescent ,Cyclophosphamide ,Azathioprine ,Kidney Function Tests ,urologic and male genital diseases ,Methylprednisolone ,Gastroenterology ,Antibodies, Antineutrophil Cytoplasmic ,End stage renal disease ,Glomerulonephritis ,Maintenance therapy ,Internal medicine ,Humans ,Medicine ,Child ,Glucocorticoids ,Retrospective Studies ,Proteinuria ,business.industry ,medicine.disease ,Pediatrics, Perinatology and Child Health ,Female ,medicine.symptom ,business ,Immunosuppressive Agents ,Kidney disease ,medicine.drug - Abstract
Vasculitis associated with antineutrophil cytoplasmic autoantibodies (ANCA) can be accompanied by a focal and necrotizing glomerulonephritis that carries a high morbidity. As many as 60% of reported children with ANCA-associated glomerulonephritis progress to end-stage renal disease. Seven children (13.0+/-0.89 years, mean age +/- SEM) with both a focal and necrotizing glomerulonephritis and a positive ANCA titer are described. Presenting symptoms were constitutional (100%) and sinopulmonary (71%); additional renal features included microscopic hematuria (100%), proteinuria (71%), and renal insufficiency (71%). Acute therapy (0 to 2 weeks from diagnosis) included intravenous corticosteroids and intravenous cyclophosphamide for all patients. Induction therapy (2 weeks to 6 months from diagnosis) consisted of cyclophosphamide (100%) and daily corticosteroids (86%) for a minimum of 6 months. Maintenance therapy that followed 6 months of induction therapy consisted of alternate day steroids (100%) combined with either oral azathioprine (50%) or oral cyclophosphamide (50%). Long-term follow-up for 48+/-12 months in all seven patients revealed that only one (14%) patient had end-stage renal disease, whereas the remaining patients had microscopic hematuria (100%), proteinuria (50%), and renal insufficiency (33%). These findings suggest that early recognition and aggressive treatment of children with ANCA-associated glomerulonephritis and vasculitis may result in an improved renal outcome compared with previous reports.
- Published
- 1998
22. Dosing of steroids in small children with nephrotic syndrome
- Author
-
Sermin A. Saadeh and Rudolph P. Valentini
- Subjects
Nephrology ,Male ,medicine.medical_specialty ,Pediatrics ,Nephrotic Syndrome ,medicine.drug_class ,Body Surface Area ,Initial dose ,Anti-Inflammatory Agents ,Body weight ,Internal medicine ,medicine ,Humans ,Dosing ,Body surface area ,business.industry ,Body Weight ,Small children ,medicine.disease ,Pediatrics, Perinatology and Child Health ,Corticosteroid ,Prednisone ,Female ,business ,Nephrotic syndrome - Abstract
Sir, We read with great interest the letter sent to your journal by Hirano and Fujinaga [1] in which they describe a retrospective review of children with idiopathic nephrotic syndrome (NS) weighing 30 kg or less at their institution. Based on their results, they concluded that the onset time for relapses after initial therapy was significantly shorter for children in the body weight (BW)-based dosing group than those in the body surface area (BSA)-based group. They also found that the proportion of steroid-dependent NS was significantly higher among children in the BW-based dosing group than among those in the BSA-based group. As acknowledged by these authors, their study findings are limited by the retrospective nature of the study design as well as the small number of patients in each group. The findings of Hirano et al., similar to those which we previously published in Pediatric Nephrology [2], indicate that BW-based dosing andBSA-dosing of steroids are not equivalent when treating patients with idiopathic NS weighing
- Published
- 2013
23. The impact of change in volume and left-ventricular hypertrophy on left-ventricular mechanical dyssynchrony in children with end-stage renal disease
- Author
-
Sheetal Patel, Daisuke Kobayashi, Rudolph P. Valentini, Sanjeev Aggarwal, and Tej K. Mattoo
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Heart Ventricles ,Echocardiography, Three-Dimensional ,Left ventricular hypertrophy ,End stage renal disease ,Muscle hypertrophy ,Peritoneal dialysis ,Ventricular Dysfunction, Left ,Renal Dialysis ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Child ,Letter to the Editor ,Analysis of Variance ,Chi-Square Distribution ,Cardiac cycle ,business.industry ,Vascular surgery ,medicine.disease ,Surgery ,Cardiac surgery ,Case-Control Studies ,Pediatrics, Perinatology and Child Health ,Cardiology ,Kidney Failure, Chronic ,Female ,Hypertrophy, Left Ventricular ,Hemodialysis ,Cardiology and Cardiovascular Medicine ,business ,Peritoneal Dialysis - Abstract
Left-ventricular dyssynchrony (LVD) adversely affects systolic performance and has not been previously evaluated in children with end-stage renal disease (ESRD). We hypothesized (1) that LVD in children with ESRD would be significantly increased compared with controls and (2) that volume load and left-ventricular hypertrophy (LVH) would be associated with increased LVD. This was a prospective observational study in which real-time three-dimensional echocardiographic data were acquired in 27 stable children with ESRD (13 peritoneal dialysis [PD] and 14 hemodialysis [HD]) and 29 normal controls. Data were acquired before and after an HD session. Dyssynchrony index (SDI) was defined per standard formulae and was normalized to cardiac cycle duration (SDIp). Left-ventricular mass (LVM) was obtained from M-mode echocardiography and was normalized to height2.7 (LVM index). The mean age (13.8 vs. 11.3 years) and SDI, SDIp, LVM, and LVM index were significantly greater among children with ESRD than among controls (p
- Published
- 2011
24. Membranous nephropathy in children: clinical presentation and therapeutic approach
- Author
-
Shina Menon and Rudolph P. Valentini
- Subjects
Nephrology ,medicine.medical_specialty ,Pediatrics ,Nephrotic Syndrome ,Cyclophosphamide ,Biopsy ,Angiotensin-Converting Enzyme Inhibitors ,Glomerulonephritis, Membranous ,Membranous nephropathy ,Internal medicine ,medicine ,Humans ,Child ,Antihypertensive Agents ,Educational Review ,Membranous glomerulonephritis ,Proteinuria ,Chlorambucil ,business.industry ,medicine.disease ,Discontinuation ,Treatment Outcome ,Membranous glomerulopathy ,Pediatrics, Perinatology and Child Health ,Immunology ,Hypertension ,Cyclosporine ,Steroids ,Azotemia ,medicine.symptom ,business ,Nephrotic syndrome ,Immunosuppressive Agents ,medicine.drug - Abstract
The approach to the pediatric patient with membranous nephropathy (MN) can be challenging to the practitioner. The clinical presentation of the child with this histologic entity usually involves some degree of proteinuria ranging from persistent, subnephrotic-ranged proteinuria to overt nephrotic syndrome. Patients often have accompanying microscopic hematuria and may have azotemia or mild hypertension. Children presenting with nephrotic syndrome are often steroid resistant; as such, their biopsy for steroid-resistant nephrotic syndrome results in the diagnosis of MN. The practitioner treating MN in the pediatric patient must weigh the risks of immunosuppressive therapy against the benefits. In general, the child with subnephrotic proteinuria and normal renal function can likely be treated conservatively with angiotensin blockade (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) without the need for immunosuppressive therapy. Those with nephrotic syndrome are usually treated with steroids initially and often followed by alkylating agents (cyclophosphamide or chlorambucil). Calcineurin inhibitors may also be useful, but the relapse rate after their discontinuation remains high. The absence of controlled studies in children with MN makes treatment recommendations difficult, but until they are available, using the patient’s clinical presentation and risk of disease progression appears to be the most prudent approach.
- Published
- 2009
25. Hypercalcemia in pediatric acute megakaryocytic leukemia: case report and review of the literature
- Author
-
Ibrahim Ahmed, Rudolph P. Valentini, Madhvi Rajpurkar, Muna Qayed, and Barbara Cushing
- Subjects
musculoskeletal diseases ,Male ,medicine.medical_specialty ,endocrine system diseases ,medicine.medical_treatment ,Pamidronate ,Pediatric Acute Megakaryocytic Leukemia ,Leukemia, Megakaryoblastic, Acute ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Intensive care medicine ,Chemotherapy ,Bone Density Conservation Agents ,Diphosphonates ,business.industry ,nutritional and metabolic diseases ,Infant ,Hematology ,medicine.disease ,Radiography ,Leukemia ,Bone Diseases, Metabolic ,Oncology ,Pediatrics, Perinatology and Child Health ,Etiology ,Hypercalcemia ,Complication ,business ,hormones, hormone substitutes, and hormone antagonists - Abstract
Summary: Hypercalcemia has been described as a possible complication of many pediatric malignancies. Here, we report an 8-month-old non-Down syndrome infant with acute megakaryocytic leukemia and severe hypercalcemia at presentation. A review of the literature reveals that this is the first case of hypercalcemia complicating acute megakaryocytic leukemia reported in the pediatric literature. His initial workup, and the course of management and outcome, is described in detail. Though the etiology of this complication remains unclear, our experience suggests that early institution of chemotherapy along with supportive care is the best treatment for control of hypercalcemia.
- Published
- 2009
26. Fibrillary glomerulonephritis and renal failure in a child with systemic lupus erythematosus
- Author
-
Xu Zeng, Rudolph P. Valentini, and Shina Menon
- Subjects
Nephrology ,Male ,medicine.medical_specialty ,Pathology ,Adolescent ,Lupus nephritis ,End stage renal disease ,Glomerulonephritis ,immune system diseases ,Glomerulopathy ,Internal medicine ,medicine ,Humans ,Lupus Erythematosus, Systemic ,skin and connective tissue diseases ,Lupus erythematosus ,business.industry ,Fibrillary Glomerulonephritis ,medicine.disease ,Pediatrics, Perinatology and Child Health ,Kidney Failure, Chronic ,Rituximab ,business ,medicine.drug - Abstract
Fibrillary glomerulonephritis (FGN) is a rare immune-mediated glomerulopathy characterized by randomly arranged immunoglobulin (Ig) deposits on electron microscopy. Only seven pediatric cases have been reported, and the incidence in adults is about 1.5%. A 12-year-old boy presented with systemic lupus erythematosus (SLE) with World Health Organization Class IV lupus nephritis. A repeat biopsy carried out due to a poor response to standard immunosuppressive therapy and worsening renal functions revealed diffuse proliferative glomerulonephritis with fibrillary deposits. Despite aggressive immunosuppression with plasmapheresis and rituximab, the patient developed end stage renal disease. This is an atypical pediatric case characterized by SLE-associated FGN and a poor prognosis.
- Published
- 2009
27. Two-dose daclizumab induction in pediatric renal transplantation
- Author
-
Tej K. Mattoo, Amrish Jain, Rudolph P. Valentini, Miguel S. West, Scott A. Gruber, and Abubakr A. Imam
- Subjects
Male ,medicine.medical_specialty ,Daclizumab ,Adolescent ,medicine.medical_treatment ,Single Center ,Antibodies, Monoclonal, Humanized ,Prednisone ,Medicine ,Humans ,Child ,Kidney transplantation ,Retrospective Studies ,Transplantation ,Dose-Response Relationship, Drug ,business.industry ,Antibodies, Monoclonal ,Immunosuppression ,medicine.disease ,Kidney Transplantation ,Tacrolimus ,Surgery ,Regimen ,Child, Preschool ,Immunoglobulin G ,Pediatrics, Perinatology and Child Health ,Kidney Failure, Chronic ,Female ,business ,Immunosuppressive Agents ,medicine.drug - Abstract
DCZ, an IL-2 receptor antagonist, has been widely used for induction therapy in pediatric and adult solid organ transplantation. Originally, it was recommended as a five-dose regimen; however, fewer doses may be efficacious and less costly for prevention of rejection. There is limited experience with the use of fewer doses in pediatric renal transplantation. We retrospectively reviewed the outcomes of 26 primary pediatric renal transplants performed at a single center between June 2004 and May 2007 receiving induction therapy with two-dose DCZ (1.5 mg/kg preoperatively and day seven post-transplant). Maintenance immunosuppression included tacrolimus, MMF, and prednisone in all patients. Forty-six percent were African American and 92% were deceased-donor transplants. After a mean follow-up of 17.8 ± 7.5 months, acute rejection was noted in 11.5% and graft survival was 92.3%. CMV infection occurred in 11.5%, but no case of BK nephropathy or post-transplant lymphoproliferative disorder was observed. Our preliminary results suggest that induction therapy with two-dose DCZ was convenient, economical, and effective in preventing rejection episodes without an increase in adverse events or hospital stay. Larger randomized clinical trials with longer duration of follow-up are needed to more fully validate the use of this regimen in pediatric renal transplantation.
- Published
- 2008
28. Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children
- Author
-
Tej K. Mattoo, Daniel Eggleston, Rudolph P. Valentini, Gaurav Kapur, Maheen Ahmed, and Amrish Jain
- Subjects
Nephrology ,Male ,medicine.medical_specialty ,Adolescent ,Urology ,urologic and male genital diseases ,Cicatrix ,Internal medicine ,Medicine ,Humans ,DMSA scan ,Child ,Radionuclide Imaging ,Retrospective Studies ,Ultrasonography ,business.industry ,Renal ultrasound ,Infant ,Retrospective cohort study ,Renal scarring ,Dimercaptosuccinic acid ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Hypertension ,Technetium Tc 99m Dimercaptosuccinic Acid ,Etiology ,Female ,Kidney Diseases ,Radiology ,Radiopharmaceuticals ,business ,medicine.drug - Abstract
Renal scarring is known to be associated with hypertension. The primary objective of this study was to investigate the prevalence of renal scarring in children referred to our clinic with hypertension. The secondary objective was to compare renal ultrasound (US) examination with dimercaptosuccinic acid (DMSA) renal scan in diagnosing renal scars in these patients. The study included 159 patients who underwent DMSA renal scan as well as renal US for the evaluation of hypertension of unknown etiology. Thirty-three (21%) patients were found to have renal scars; their demographic details, including mean age and gender distribution, were not significantly different from those without renal scars. In comparison with the DMSA renal scan, sensitivity and specificity of renal US in diagnosing renal scars were 36% and 94%, respectively. In our study, in which the prevalence of scarring was 21%, this gave positive predictive and negative predictive values of 63% and 85%, respectively. In conclusion, our study indicates that renal scarring is present in 21% of otherwise healthy children who are evaluated for newly diagnosed hypertension, and renal US is not a sensitive imaging modality to rule out renal scarring.
- Published
- 2007
29. Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia
- Author
-
A. Kim Ritchey, Abubakr Imam, Rudolph P. Valentini, Michael L. Moritz, Indira Warrier, Yaddanapudi Ravindranath, Demetrius Ellis, and Ron Shapiro
- Subjects
Hemolytic anemia ,medicine.medical_specialty ,Nephrotic Syndrome ,Time Factors ,Gastroenterology ,Tacrolimus ,Internal medicine ,medicine ,Humans ,Kidney transplantation ,Antibacterial agent ,Sirolimus ,Transplantation ,business.industry ,Immunoglobulins, Intravenous ,medicine.disease ,Kidney Transplantation ,Calcineurin ,surgical procedures, operative ,Treatment Outcome ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Immunology ,Anemia, Hemolytic, Autoimmune ,Autoimmune hemolytic anemia ,business ,Immunosuppressive Agents ,medicine.drug - Abstract
Autoimmune hemolytic anemia (AIHA) has been reported to occur after renal transplantation, and typically does so in the first few weeks post-transplant. We report on a 3-yr-old child who developed cold AIHA nearly 1 yr after an ABO identical, living donor renal transplant from his mother. Numerous transfusions, pulse steroids, repeat plasma exchange treatments, and IVIG were unsuccessful. Nearly 3 wk into his illness, tacrolimus was changed to cyclosporine, and then to sirolimus, and resulted in a prompt response. He currently has a normal renal function and a normal hemoglobin level on sirolimus monotherapy.
- Published
- 2006
30. Effect of dialysis on all trans retinoic acid levels in a child with acute promyelocytic leukemia and renal failure
- Author
-
Yaddanapudi Ravindranath, Daniel A.C. Frattarelli, Nancy Fassinger, Madhvi Rajpurkar, Rudolph P. Valentini, Indulekha Warrier, and Patricia Alcasabas
- Subjects
Acute promyelocytic leukemia ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Multiple Organ Failure ,Administration, Oral ,Tretinoin ,Gastroenterology ,Drug Administration Schedule ,Peritoneal dialysis ,Leukemia, Promyelocytic, Acute ,immune system diseases ,Renal Dialysis ,Internal medicine ,Hemofiltration ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,Humans ,Renal replacement therapy ,Renal Insufficiency ,Intensive care medicine ,neoplasms ,Dialysis ,Chemotherapy ,Dose-Response Relationship, Drug ,business.industry ,organic chemicals ,Hematology ,medicine.disease ,biological factors ,Leukemia ,Treatment Outcome ,Oncology ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Hemodialysis ,business ,Follow-Up Studies - Abstract
All trans retinoic acid (ATRA) combined with chemotherapy has become the mainstay of treatment for patients with acute promyelocytic leukemia (APL). Renal dysfunction (RD) is commonly seen in patients with APL. We describe a patient with APL and multi-organ failure, who was on chronic veno-venous hemofiltration followed by hemodialysis (HD) and later peritoneal dialysis (PD), who received ATRA. ATRA levels were assessed as the body clearance of ATRA in children on HD and/or PD was unknown. Neither HD nor PD significantly affected ATRA levels, suggesting that dose modifications of ATRA may not be necessary for children with these forms of renal replacement therapy.
- Published
- 2006
31. MR angiography in the evaluation of a renovascular cause of neonatal hypertension
- Author
-
Rudolph P. Valentini, Amira E. Mustafa, Abubakr Imam, Tej K. Mattoo, and David A. Bloom
- Subjects
Male ,medicine.medical_specialty ,Radiography ,medicine.medical_treatment ,Gadolinium ,urologic and male genital diseases ,Kidney ,Renal Artery Obstruction ,Magnetic resonance angiography ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,cardiovascular diseases ,Kidney surgery ,Neuroradiology ,medicine.diagnostic_test ,business.industry ,Gold standard ,Infant, Newborn ,medicine.disease ,Nephrectomy ,Stenosis ,Hypertension, Renovascular ,Pediatrics, Perinatology and Child Health ,Cardiology ,Radiology ,Abnormality ,business ,Magnetic Resonance Angiography ,circulatory and respiratory physiology - Abstract
Neonatal hypertension occurs in 2% of all infants and it is caused by renovascular abnormalities in 70% of these infants. The gold standard for diagnosing renovascular disease is conventional renal angiography. However, in neonates the procedure is not commonly used because of its invasive and technically challenging nature. MRI and MR angiography (MRA) are less invasive yet reliable means of detecting renovascular disease in adults. There is minimal literature on the use of MRI/MRA in neonatal hypertension. We report a neonate with hypertension secondary to a renovascular abnormality in which MRI/MRA was helpful in uncovering segmental renal artery stenosis. The infant underwent partial nephrectomy with subsequent resolution of his hypertension. Further studies are needed to validate the use of MRI/MRA in the evaluation of neonatal hypertension.
- Published
- 2005
32. MRI detection of atrophic kidney in a hypertensive child with a single kidney
- Author
-
Scott E. Langenburg, Rudolph P. Valentini, J. Michael Zerin, Tej K. Mattoo, and Abubakr A. Imam
- Subjects
Nephrology ,medicine.medical_specialty ,medicine.medical_treatment ,Renal artery stenosis ,Kidney ,Magnetic resonance angiography ,Internal medicine ,medicine ,Humans ,Child ,Renal agenesis ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,medicine.disease ,Renal dysplasia ,Magnetic Resonance Imaging ,Nephrectomy ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Hypertension ,Female ,Radiology ,Atrophy ,business ,Magnetic Resonance Angiography - Abstract
The role of magnetic resonance imaging (MRI) in the work-up of secondary causes of pediatric hypertension is typically restricted to that of renovascular causes where main renal artery stenosis is suspected. We report a case of a 10-year-old female child with hypertension, who was thought to have unilateral renal agenesis, because only a solitary left kidney could be visualized on both ultrasound and renal scintigraphy. Our patient underwent magnetic resonance imaging because of suspected renal artery stenosis in her solitary left kidney. At MRI she was found to have a normal left kidney. However, a very tiny, atrophic right kidney was also visualized. A laparoscopic right nephrectomy was performed, which resulted in complete resolution of her hypertension. This case illustrates a possible additional role for MRI in a very small subset of pediatric hypertensive patients: those with a single kidney on ultrasound.
- Published
- 2005
33. An adolescent on peritoneal dialysis with acute encephalopathy: questions
- Author
-
Rudolph P. Valentini, Gaurav Kapur, Rossana Baracco, Amrish Jain, Tej K. Mattoo, Lawrence Ku, and Murty Adabala
- Subjects
medicine.medical_specialty ,Text mining ,Nephrology ,business.industry ,medicine.medical_treatment ,Pediatrics, Perinatology and Child Health ,Acute encephalopathy ,medicine ,Intensive care medicine ,business ,Peritoneal dialysis - Published
- 2013
34. Treatment of vancomycin overdose using high-efficiency dialysis membranes
- Author
-
John J. Gardner, Rudolph P. Valentini, Timothy E. Bunchman, Norma J. Maxvold, Timothy L. Kudelka, and Theresa Mottes
- Subjects
Nephrology ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Extracorporeal ,Renal Dialysis ,Vancomycin ,Internal medicine ,Hemofiltration ,medicine ,Humans ,Antibacterial agent ,business.industry ,Infant ,Membranes, Artificial ,Hemoperfusion ,Surgery ,Anti-Bacterial Agents ,Anesthesia ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Toxicity ,Female ,Hemodialysis ,Drug Overdose ,business ,medicine.drug - Abstract
Two children underwent acute hemodialysis using high-efficiency dialysis membranes for vancomycin intoxication (plasma levels 238 microg/ml and 182 microg/ml). During a 3-h treatment, plasma vancomycin removal was on average 60%, with a calculated vancomycin half-life (t(1/2)) of 2 h. This is in contrast to a recent report using charcoal hemoperfusion for vancomycin intoxication (plasma level of 137 microg/ml), which resulted in a 40% relative plasma clearance and a calculated vancomycin t(1/2) of 12.5 h for a 4-h treatment. The choice of optimal modality for clearing a toxin should take into account the availability of equipment, protein or lipid binding of the toxin, and inherent risks of charcoal hemofiltration (large extracorporeal circuit, reversible hypocalcemia, heat loss, reversible coagulation defects) versus risks of high-efficiency hemodialysis (large extracorporeal circuit).
- Published
- 1999
35. Neoral induction in pediatric renal transplantation
- Author
-
David B. Kershaw, Aileen B. Sedman, William E. Smoyer, Brenda J. Pontillo, Catherine M. Brown, Joseph T. Flynn, Jill Sandvordenker, Timothy E. Bunchman, Rulan S. Parekh, and Rudolph P. Valentini
- Subjects
Nephrology ,Graft Rejection ,Male ,medicine.medical_specialty ,Population ,Urology ,Blood Pressure ,chemistry.chemical_compound ,Internal medicine ,medicine ,Humans ,Dosing ,education ,Child ,education.field_of_study ,Creatinine ,business.industry ,Area under the curve ,Ciclosporin ,medicine.disease ,Kidney Transplantation ,Surgery ,Transplantation ,chemistry ,Pediatrics, Perinatology and Child Health ,Cyclosporine ,Female ,business ,Immunosuppressive Agents ,medicine.drug ,Kidney disease - Abstract
Neoral was instituted in pediatric renal transplant patients with the hypothesis it would have more predictable kinetics than Sandimmun. However, significant questions have arisen concerning potential toxicity and dosing interval related to its rapid absorption with subsequent high initial peak. This is compounded by the fact that children appear to metabolize cyclosporine at a greater rate than adults. This combination of a rapid peak and rapid absorption may then result in lower trough levels at 12 h. We compared the trough cyclosporine levels of nine children who received Neoral with nine who received Sandimmun at the time of initial transplantation. More frequent dosing (every 8 h) was required in the Neoral population compared with the Sandimmun population for the 1st month in order to obtain comparable trough levels. Beyond the initial 4-6 weeks, trough levels were similar for Neoral and Sandimmun. Whereas 1-month creatinine levels and blood pressures were similar, the number of blood pressure medications was significantly higher in the Neoral group. At 5.5 +/- 1.1 months' followup, a single patient in the current Neoral group and in the retrospective Sandimmun group each experienced a single OKT3 allograft-treated rejection. We suggest that the area under the curve is different in Neoral than Sandimmun, and the initial dosing frequency may need to be adjusted accordingly.
- Published
- 1998
36. ERRATA
- Author
-
Amrish Jain, Gaurav Kapur, Rudolph P. Valentini, Abubakr A. Imam, and Tej K. Mattoo
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Severe edema ,medicine ,In patient ,Idiopathic Nephrotic Syndrome ,business - Published
- 2007
37. IgM OR C1q MESANGIAL LABELING DO NOT DEFINE UNIQUE GLOMERULOPATHIES IN CHILDREN. † 2214
- Author
-
A. James McAdams, Rudolph P Valentini, and Thomas R. Welch
- Subjects
business.industry ,Pediatrics, Perinatology and Child Health ,Immunology ,Medicine ,urologic and male genital diseases ,business ,medicine.disease ,Nephrotic syndrome - Abstract
Although patients with nephrotic syndrome and IgM or C1q mesangial labeling are sometimes said to have a high propensity to develop ESRD, there is controversy as to the specificity of such labeling.
- Published
- 1996
38. Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners
- Author
-
Rudolph P. Valentini, Deepa H. Chand, and Elaine S. Kamil
- Subjects
Nephrology ,medicine.medical_specialty ,Catheterization, Central Venous ,medicine.medical_treatment ,Population ,Pediatrics ,Peritoneal dialysis ,Arteriovenous Shunt, Surgical ,Catheters, Indwelling ,Blood vessel prosthesis ,Renal Dialysis ,Internal medicine ,medicine ,Humans ,Renal replacement therapy ,Pediatrics, Perinatology, and Child Health ,Intensive care medicine ,education ,Child ,Educational Review ,Arteriovenous fistula ,education.field_of_study ,business.industry ,Incidence ,Graft Occlusion, Vascular ,Vascular surgery ,Blood Vessel Prosthesis ,Transplantation ,Hemodialysis ,Pediatrics, Perinatology and Child Health ,Pediatric nephrology ,Kidney Failure, Chronic ,Arteriovenous graft ,business ,Central venous catheter - Abstract
Recent data indicate that the incidence of end-stage renal disease (ESRD) in pediatric patients (age 0–19 years) has increased over the past two decades. Similarly, the prevalence of ESRD has increased threefold over the same period. Hemodialysis (HD) continues to be the most frequently utilized modality for renal replacement therapy in incident pediatric ESRD patients. The number of children on HD exceeded the sum total of those on peritoneal dialysis and those undergoing pre-emptive renal transplantation. Choosing the best vascular access option for pediatric HD patients remains challenging. Despite a national initiative for fistula first in the adult hemodialysis population, the pediatric nephrology community in the United States of America utilizes central venous catheters as the primary dialysis access for most patients. Vascular access management requires proper advance planning to assure that the best permanent access is placed, seamless communication involving a multidisciplinary team of nephrologists, nurses, surgeons, and interventional radiologists, and ongoing monitoring to ensure a long life of use. It is imperative that practitioners have a long-term vision to decrease morbidity in this unique patient population. This article reviews the various types of pediatric vascular accesses used worldwide and the benefits and disadvantages of these various forms of access.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.